Petros Pharmaceuticals, Inc. (PTPI)
| Market Cap | 15.86M |
| Revenue (ttm) | 7.93M |
| Net Income (ttm) | -11.87M |
| Shares Out | 20.68M |
| EPS (ttm) | -0.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 119,574 |
| Open | 0.790 |
| Previous Close | 0.780 |
| Day's Range | 0.760 - 0.795 |
| 52-Week Range | 0.646 - 5.200 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 16, 2022 |
About PTPI
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York. [Read more...]
Financial Performance
In 2021, PTPI's revenue was $7.81 million, a decrease of -18.29% compared to the previous year's $9.56 million. Losses were -$8.99 million, -56.35% less than in 2020.
Financial StatementsNews
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
NEW YORK, NY / ACCESSWIRE / August 15, 2022 / Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (NASDAQ:PTPI), a leading provider of therapeutics for men's health, today announced financial resul...
What Is Going on With Petros Pharmaceuticals (PTPI) Stock Today?
An absolutely incredible mover today, Petros Pharmaceuticals (NASDAQ: PTPI ) has seen some of the most impressive price action I've seen in some time. This morning, PTPI stock surged more than 260% on r...
Petros Pharmaceuticals Responds to Fraudulent Press Release
NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today confirmed that a press release issued on July 28, 2022...
Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per share
Petros Pharmaceuticals to become a privately-owned company operating independently as part of Henry Crown and Company's healthcare platform
Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew Pinsky
Dr. Drew to Raise Awareness of Petros Pharmaceuticals' Mission in The Men's Health Category and STENDRA® (avanafil) Dr. Drew to Raise Awareness of Petros Pharmaceuticals' Mission in The Men's Health Cat...
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
NEW YORK, May 16, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced financial results...
Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company's Novel Topical Investigational Treatment for P...
Company Is Developing H-100 as Potentially the First FDA-Approved, Nanoparticle-Based Topical Treatment Designed to Provide Improved and Sustained Local Medication Permeation Against Peyronie's Disease,...
Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022
NEW YORK, April 27, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer...
Petros Pharmaceuticals, Inc. Engages Massachusetts General Hospital in a Sponsored Research Agreement for Tissue-Spec...
Sensor Measures Oxygen Levels Within Specific Human Tissue, Potentially Allowing Biosensor Feedback of Erectile Device Therapy Sensor Measures Oxygen Levels Within Specific Human Tissue, Potentially All...
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (“Petros” or “the Company”) (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces financial resul...
Petros Pharmaceuticals to Present at the Q1 Investor Summit Conference
NEW YORK, March 03, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, announces today that President and Chief Commercial Officer...
Petros Pharmaceuticals Partners with Celebrity Physician Dr. Drew to Bring Awareness to Men's Health
NEW YORK, Feb. 1, 2022 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces that it has signed a collaboration agreement with...
Short Squeeze Stocks: ISIG, RELI and 3 Others Experts Think Are Ready to Pop
These five top short squeeze stocks are among the top speculative plays investors and traders are watching in today's market. The post Short Squeeze Stocks: ISIG, RELI and 3 Others Experts Think Are Rea...
5 Short Squeeze Candidates To Watch: Insignia Systems, American Virtual Cloud Top List Again, Reliance Global Rejoins
Potential short squeeze plays gained steam in 2021 with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
Petros Pharmaceuticals Announces Closing of $7.5 Million Offering
NEW YORK, Dec. 28, 2021 Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously announced registered direct offeri...
5 Short Squeeze Candidates To Watch: Biofrontera Rejoins And Tops List, 2 New Names Enter Leaderboard
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile ex...
Petros Pharmaceuticals Announces $7.5 Million Offering
NEW YORK, Dec. 22, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that it has entered into definitive agreements w...
5 Short Squeeze Candidates To Watch: Petros Pharmaceuticals, iSpecimen Top The List Again
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge movie. GameStop Corp (NYSE:GME) and AMC Entertainment Holdings (NYSE:AMC) are two high-profile e...
5 Short Squeeze Candidates To Watch: Petros Pharma Tops List With 254% Cost To Borrow, One Of Highest Figures On Record
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next huge move. GameStop Corp (NYSE: GME) and AMC Entertainment Holdings (NYSE: AMC) are two high-profile ...
PTPI Stock Pops on Short Squeeze Hopes: 10 Things to Know
PTPI stock is up nearly 40% today as investors continue to target Petros Pharmaceuticals for a short squeeze. Here's what to know.
Petros Pharmaceuticals Announces Closing of $10 Million Offering
NEW YORK, Dec. 2, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced the closing of its previously announced registere...
Petros Pharmaceuticals Announces $10 Million Offering
NEW YORK, Nov. 30, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announces that it has entered into definitive agreements w...
What's Going On With Petros Pharmaceuticals Stock Today?
Petros Pharmaceuticals Inc (NASDAQ: PTPI) is soaring on abnormally high volume Monday despite no apparent news catalyst. Petros Pharmaceuticals' average session volume is about 6.4 million over a 100-d...
PTPI Stock: The Short-Squeeze Buzz That Has Petros Pharmaceuticals Rocketing Today
Petros Pharmaceuticals (PTPI) stock is taking off in pre-market trading on Monday as short-squeeze talk on social media pushes shares higher. The post PTPI Stock: The Short-Squeeze Buzz That Has Petros ...